ic31
Small moleculeexperimental
Clinical trial activity
7 trials · 16 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2008 (NCT01049282)
Timeline
Indications
Mechanism of action
- UnclearImmunity, active
Unclear immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ic31
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03512249 | Phase 2 | Sep 30, 2018 | Aeras, Statens Serum Institut |
| NCT03265977 | Phase 2 | Jun 30, 2018 | Aeras, Aurum Institute, National Institute for Medical Research, Tanzania, South African Tuberculosis Vaccine Initiative (SATVI), Statens Serum Institut, University of Bergen, University of Copenhagen, University of Oslo |
| NCT02503839 | Phase 1 | Nov 1, 2015 | Osaka University, Statens Serum Institut, University of Bergen, University of Oslo |
| NCT02496897 | Phase 1 | Jul 1, 2015 | Altimmune, Inc., University of London |
| NCT02378207 | Phase 1 | May 1, 2015 | Aeras, Desmond Tutu HIV Foundation, HIV Vaccine Trials Network, Sanofi-Aventis, Statens Serum Institut, University of Washington |
| NCT02375698 | Phase 1 | Nov 21, 2014 | Aeras, Statens Serum Institut |
| NCT01049282 | Phase 1 | Dec 1, 2008 | Armauer Hansen Research Institute, Ethiopia, Statens Serum Institut |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (16)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Statens Serum Institut | Academic/Hospital | 6 | 1 | 2 | 2008 |
| Aeras | Academic/Hospital | 4 | 4 | 2 | 2014 |
| University of Bergen | Academic/Hospital | 2 | 0 | 2 | 2015 |
| University of Oslo | Academic/Hospital | 2 | 1 | 2 | 2015 |
| Altimmune, Inc. | For profit | 1 | 1 | 1 | 2015 |
| Armauer Hansen Research Institute, Ethiopia | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Aurum Institute | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Desmond Tutu HIV Foundation | Academic/Hospital | 1 | 0 | 1 | 2015 |
| HIV Vaccine Trials Network | Academic/Hospital | 1 | 0 | 1 | 2015 |
| National Institute for Medical Research, Tanzania | Government | 1 | 0 | 1 | 2018 |
| Osaka University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Sanofi-Aventis | For profit | 1 | 0 | 1 | 2015 |
| South African Tuberculosis Vaccine Initiative (SATVI) | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Copenhagen | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2015 |
16 organizations
Page 1 / 1